
Molecular Templates MTEM
Quartalsbericht 2024-Q2
hinzugefügt 16.05.2026
Molecular Templates P/B 2011-2026 | MTEM
P/B Jährlich Molecular Templates
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.39 | -0.0844 | 2.59 | 9.19 | 5.48 | 1.39 | 1.59 | -29.4 | 6.05 | -103 | -132 | -199 | 149 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 149 | -199 | -22 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
1.66 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
0.115 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
7.09 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
AstraZeneca PLC
AZN
|
2.82 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.036 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
7.43 | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
-0.0532 | - | -32.59 % | $ 7.61 M | ||
|
Esperion Therapeutics
ESPR
|
-1.86 | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
21.4 | $ 34.45 | 4.74 % | $ 927 M | ||
|
Midatech Pharma plc
MTP
|
173 | - | -18.52 % | $ 27.3 M | ||
|
Forte Biosciences
FBRX
|
5.5 | $ 20.31 | 1.2 % | $ 263 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | ||
|
Grifols, S.A.
GRFS
|
0.525 | $ 8.19 | 4.46 % | $ 5.57 B | ||
|
Celyad Oncology SA
CYAD
|
0.539 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
1.01 | $ 6.82 | 1.94 % | $ 187 M | ||
|
Generation Bio Co.
GBIO
|
0.879 | - | - | $ 344 M | ||
|
IMV
IMV
|
-1.04 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
4.34 | - | - | $ 3.67 B | ||
|
BioNTech SE
BNTX
|
1.15 | $ 90.36 | 2.93 % | $ 21.8 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.62 | -0.61 % | $ 431 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.0503 | - | -4.36 % | $ 27 M | ||
|
Compugen Ltd.
CGEN
|
1.25 | $ 2.71 | -0.92 % | $ 253 M | ||
|
Anika Therapeutics
ANIK
|
1.12 | $ 15.14 | 2.16 % | $ 217 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.12 | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
3.77 | $ 97.08 | 1.55 % | $ 19 B | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.458 | - | - | $ 26.5 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
0.505 | $ 3.39 | 4.17 % | $ 5.58 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
Coherus BioSciences
CHRS
|
3.71 | $ 1.51 | 2.03 % | $ 177 M | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 20.47 | 4.97 % | $ 2.6 B | ||
|
Allena Pharmaceuticals
ALNA
|
3.16 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K |